1. Carter BJ . Adeno-associated virus vectors in clinical trials. Hum Gene Ther 2005; 16: 541550.
2. Warrington KH, Herzog RW . Treatment of human disease by adeno-associated viral gene transfer. Hum Genet 2006; 119: 571603.
3. Fiandaca M, Forsayeth J, Bankiewicz K . Current status of gene therapy trials for Parkinson's disease. Exp Neurology 2008; 209: 5157.
4. 21CFR parts 120 and 211current good manufacturing practice in manufacturing, processing, packing or holding of drugs general and current good manufacturing practice for finished pharmaceuticals. http://www.gpoaccess.gov/cfr/index.html .
5. US Dept Health Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for FDA and sponsors: content and review of Chemistry, Manufacturing, and Control (CMC) information for human gene therapy Investigational New Drug applications (INDs). November, 2004. http://www.fda.gov/cber/guidelines.htm .